Tottenham Acquisition I Ltd. (NASDAQ:TOTA) announced in an 8-K filing that its shareholders approved its combination with biopharmaceutical firm Clene Nanomedicine Inc. at a special meeting earlier today.
The transaction was approved unanimously with 92.3% of shares participating, however Tottenham did not divulge redemption figures in the filing. The company went into the vote with an estimated $11.02 per share in trust and previously saw 58.6% of its shares redeemed through a series of extension votes. But, having opened ahead of the vote at $11.88, any further redemptions were likely limited.
Tottenham initially announced its $542 million combination with Clene Nanomedicine on September 2. Clene has developed a novel orally administered drug platform that could potentially treat multiple sclerosis, Parkinson’s disease, and ALS, with one Phase 3 trial and multiple Phase 2 clinical studies ongoing. It is also launching two additional Phase 2 COVID-19 studies with a second nanotherapeutic asset, CNM-ZnAg, in Brazil and Russia.
Several measures up for a vote at the meeting passed unanimously, however 131,903 shares voted against a number of proposed amendments to the combined company’s charter. For a full list of measures on the ballot as well as vote tallies, click HERE.
A look at Plus’ software-first approach to autonomous trucking. After years of investment and excitement, the dawn of self-driving cars and trucks is now here. The question now is which business model among autonomous driving technology companies will win out? This week, we speak with David Liu, CEO of autonomous trucking company Plus. Plus announced...
At the SPAC of Dawn One thing that SPAC investors can typically count on while their money is invested in a SPAC’s trust is that it is going to grow one way or the other between now and their next redemption opportunity, but the devil can occasionally be in the details. In 2024, it became...
Thunderstone has filed for a $50 million SPAC to put a new first-time Asia-based team in action on a generalist hunt. The new SPAC is offering investors a right to a 1/8 share in each unit with 18 months to initially complete a business combination. It is the 8th fresh S-1 filed with underwriter D....
At the SPAC of Dawn In a trading session that may find itself built around the release of Fed minutes at 2 pm ET this afternoon, a pair of SPAC targets have added their own fresh information to the mix. Enterprise AI firm Fusemachines, which has a pending combination with CSLM (OTC:CSLMF), put out a...
Globa Terra Acquisition Corporation (NASDAQ:GTERU) announced the pricing of its $152 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GTERU”, Wednesday, July 9, 2025. The new SPAC plans to mount a search for a target in the agriculture, agtech or biotech sectors with an emphasis on water...